Taclonex (LEO Pharma Inc.)


Welcome to the PulseAid listing for the Taclonex drug offered from LEO Pharma Inc.. This Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: LEO Pharma Inc.
NON-PROPRIETARY NAME: calcipotriene and betamethasone dipropionate
SUBSTANCE NAME: CALCIPOTRIENE HYDRATE; BETAMETHASONE DIPROPIONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC],Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA]
ROUTE: TOPICAL
DOSAGE FORM: OINTMENT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2008-06-01
END MARKETING DATE: 0000-00-00


Taclonex HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTaclonex from LEO Pharma Inc.
LABELER NAME: LEO Pharma Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 50; .5(ug/g; mg/g)
START MARKETING DATE: 2008-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 50222-227_dd8e0682-9c71-4d38-88dd-a3abf09771d3
PRODUCT NDC: 50222-227
APPLICATION NUMBER: NDA021852

Other CALCIPOTRIENE HYDRATE; BETAMETHASONE DIPROPIONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
LEO Pharma Inc.Taclonex
Perrigo New York IncCalcipotriene and Betamethasone Dipropionate
Physicians Total Care, Inc.Taclonex